Search
MSK physician-scientist Prasad Adusumilli is focused on developing more-effective immunotherapy approaches for treating tumors in the chest.
During the June 8 edition of “MSK Science Spotlight,” radiochemist Jason Lewis, PhD, will share his perspectives on “Defying the Limitations of Antibodies for Imaging and Endoradiotherapy.”
Genetic analysis reveals biomarkers and possible drug targets for malignant peripheral nerve sheath tumors.
Learn more about Memorial Sloan Kettering’s newsletter for cancer survivors, which is celebrating its tenth year of publication.
Learn about the role of radiation therapy in protecting women from breast cancer recurrence after breast-conserving surgery.
In a large-scale genomic analysis of the most common and aggressive type of ovarian cancer, researchers from Memorial Sloan Kettering and other centers identified genetic mutations and pathways that set the disease apart from other types of ovarian cancer and other solid tumors.
While BRCA genes garner most of the public's attention, they're not the only cancer-predisposition genes doctors test for.
Learn how it's possible to stay active even with two types of advanced cancer — lung cancer and mantle cell lymphoma — thanks to innovative treatments at MSK.
Descubra cómo es posible mantenerse activo incluso con dos tipos de cáncer avanzado, cáncer pulmonar y linfoma de células del manto, gracias a los tratamientos innovadores en MSK.
New MSK research finds adherence is a hurdle for home-based colorectal cancer tests; sheds new light on tumor-associated macrophages in glioblastoma; identifies statins as a promising addition to treatment for HER2-positive gastric cancer; and describes how a new single-cell transcriptome atlas opens the “black box” of early human embryo development.